⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL435435 | 1.00 | — | — | |
| SCHEMBL12940068 | 1.00 | — | — | |
| SCHEMBL14963190 | 0.79 | — | — | |
| SCHEMBL13716272 | 0.75 | — | — | |
| SCHEMBL7837665 | 0.75 | — | — | |
| SCHEMBL3214461 | 0.73 | — | — | |
| SCHEMBL127505 | 0.72 | SLC6A2 (0.31) | — | |
| SCHEMBL18019736 | 0.71 | — | — | |
| SCHEMBL436289 | 0.69 | — | — | |
| SCHEMBL9678445 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119174730-A | Module engineering self-adaptive nano platform and preparation method and application thereof | 上海交通大学 | 2024-12-24 | — | — | CN | claimed |
| EP-4017253-A1 | RNA-BASED THERAPEUTIC METHODS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIA AND / OR PROMOTE BENEFICIAL EFFECTS OF SYMBIOTIC AND COMMENSAL BACTERIA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2022-06-29 | — | — | EP | claimed |
| US-20020098270-A1 | Foodstuffs that include sulfur-containing flavorings | NESTEC S.A. | 2002-07-25 | — | — | US | claimed |
| US-20010008647-A1 | FLAVORINGS | NESTEC S.A. (CH) | 2001-07-19 | — | — | US | claimed |
| EP-0963706-A1 | Aroma precursor mixture | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1999-12-15 | — | — | EP | claimed |
| JP-11346706-A | — | — | None | — | — | JP | disclosed |
| EP-4739277-A1 | CONSENSUS PEPTIDES IN HYA | NuPep AS (NO) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739330-A1 | CONSENSUS PEPTIDES IN HYA FOR USE IN TREATING DEGENERATED JOINTS | NuPep AS (NO) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739331-A1 | CONSENSUS PEPTIDES IN HYA FOR USE IN VISCOSUPPLEMENTATION | NuPep AS (NO) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026088982-A1 | FPR1 INHIBITOR, DRUG, SEVERE DRUG ERUPTION THERAPEUTIC AGENT, AND FPR1 INHIBITOR SCREENING METHOD | 国立大学法人新潟大学 | 2026-04-30 | — | — | WO | disclosed |
| US-12496292-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2025-12-16 | — | — | US | disclosed |
| WO-2025235617-A1 | FUSOGENIC LIPID PARTICLES FOR DELIVERY OF PAYLOAD IN CELLS | NVELOP THERAPEUTICS LLC (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-0750609-A1 | ISOPRENYL TRANSFERASE INHIBITORS | Eisai Co., Ltd. (JP) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996030014-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| WO-1995025086-A1 | ISOPRENYL TRANSFERASE INHIBITORS | EISAI CO., LTD. (JP) | 1995-09-21 | — | — | WO | disclosed |
| EP-0204480-B1 | SYNTHETIC VACCINES FOR FOOT AND MOUTH DISEASE | ELI LILLY AND COMPANY (US) | 1992-07-22 | — | — | EP | disclosed |
| US-4732971-A | POLYPEPTIDES | ELI LILLY AND COMPANY (US) | 1988-03-22 | — | — | US | disclosed |
| EP-0204480-A2 | Synthetic vaccines for foot and mouth disease | ELI LILLY AND COMPANY (US) | 1986-12-10 | — | — | EP | disclosed |
| EP-0084403-B1 | SILVER HALIDE EMULSION CONTAINING A PURIFIED CYSTEINE-GLUTARALDEHYDE POLYMER FRACTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-06-04 | — | — | EP | disclosed |
| EP-0084403-A2 | Silver halide emulsion containing a purified cysteine-glutaraldehyde polymer fraction | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-07-27 | — | — | EP | disclosed |